share_log

Needham Maintains Buy on Pacira BioSciences, Lowers Price Target to $43

Needham Maintains Buy on Pacira BioSciences, Lowers Price Target to $43

Needham维持对Pacira BioSciences的买入,将目标股价下调至43美元
Benzinga ·  05/08 06:38

Needham analyst Serge Belanger maintains Pacira BioSciences (NASDAQ:PCRX) with a Buy and lowers the price target from $45 to $43.

Needham分析师塞尔吉·贝兰格维持Pacira BioSciences(纳斯达克股票代码:PCRX)的买入并将目标股价从45美元下调至43美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发